Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice

Publication Status is "Submitted" Or "In Press: 
LDEO Publication: 
Publication Type: 
Year of Publication: 
Journal Title: 
World Journal of Gastroenterology
Journal Date: 
Mar 14
Place Published: 
Tertiary Title: 
Section / Start page: 
ISBN Number: 
ISSN Number: 
Short Title: 
Accession Number: 
LDEO Publication Number: 
Call Number: 

AIM: To investigate the pathogenic role of cathepsin B and the protective effect of a cathepsin B inhibitor (CA-074Me) in fulminant hepatic failure in mice.METHODS: LPS/D-Gal N was injected into mice of the model group to induce fulminant hepatic failure; the protected group was administered CA-074me for 30 min before LPS/D-Gal N treatment; the normal group was given isochoric physiologic saline. Liver tissue histopathology was determined with HE at 2, 4, 6 and 8 h after Lps/D-Gal injection. Hepatocyte apoptosis was examined by TUNEL method. The expression of cathepsin B in liver tissues was investigated by immunohistochemistry, Western blot and RT-PCR.RESULTS: Compared with the normal group, massive typical hepatocyte apoptosis occurred in the model group; the number of apoptotic cells reached a maximum 6 h after injection. The apoptosis index (AI) in the protected group was clearly reduced (30.4 +/- 2.8 vs 18.1 +/- 2.0, P < 0.01). Cathepsin B activity was markedly increased in drug-treated mice compared with the normal group (P < 0.01). Incubation with LPS/D-Gal N at selected time points resulted in a time-dependent increase in cathepsin B activity, and reached a maximum by 8 h. The expression of cathepsin B was significantly decreased in the protected group (P < 0.01).CONCLUSION: Cathepsin B plays an essential role in the pathogenesis of fulminant hepatic failure, and the cathepsin B inhibitor CA-074me can, attenuate apoptosis and liver injury. (c) 2009 The WIG Press and Baishideng. All rights reserved.


423IDTimes Cited:0Cited References Count:19

Doi 10.3748/Wjg.15.1231